Intellia Therapeutics (NTLA) had the highest return in June 2021 by a mid-cap US stock, returning 114.2%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Intellia Therapeutics (NTLA) | June 2021 | 114.17% |
Astrana Health (ASTH) | June 2021 | 78.89% |
Clover Health Investments (CLOV) | June 2021 | 74.12% |
Global-E Online (GLBE) | June 2021 | 73.71% |
Dlocal (DLO) | June 2021 | 69.45% |
Beam Therapeutics (BEAM) | June 2021 | 63.44% |
Weatherford International (WFRD) | June 2021 | 61.78% |
Lucid (LCID) | June 2021 | 44.1% |
Doximity (DOCS) | June 2021 | 41.37% |
Lifestance Health (LFST) | June 2021 | 39.3% |
DocuSign (DOCU) | June 2021 | 38.33% |
Dillard's (DDS) | June 2021 | 36.87% |
Privia Health (PRVA) | June 2021 | 36.31% |
Crispr Therapeutics (CRSP) | June 2021 | 35.54% |
Signet Jewelers (SIG) | June 2021 | 32.73% |
Acm Research (ACMR) | June 2021 | 32.53% |
Grupo Simec SAB de CV ADR (SIM) | June 2021 | 30.93% |
Xometry (XMTR) | June 2021 | 30.41% |
Trade Desk (TTD) | June 2021 | 29.98% |
Monday (MNDY) | June 2021 | 29.13% |
Clear Secure (YOU) | June 2021 | 29.03% |
TransMedics (TMDX) | June 2021 | 28.6% |
Protagonist Therapeutics (PTGX) | June 2021 | 28.23% |
Himax Technologies (HIMX) | June 2021 | 28.01% |
Enphase Energy (ENPH) | June 2021 | 27.08% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.